Profile data is unavailable for this security.
About the company
Elutia Inc. is a commercial-stage company, which has developed a portfolio of products using both human and porcine tissue. Its portfolio of products spans the Women’s Health and Cardiovascular markets. In Women’s Health, it offers SimpliDerm, a novel biological matrix that leverages the inherent science of natural healing processes. SimpliDerm's design uses human-based hydrated acellular dermal matrix (ADM), which mitigates inflammation and enhances tissue incorporation. In Cardiovascular, it sells its specialized porcine small intestine submucosa for use as an intracardiac and vascular patch, as well as for pericardial reconstruction. In addition, its TYKE product is designed for use in the neonatal patient population. It is focused on advancing NXT-41x, a biomatrix that directly addresses the root causes of reconstruction infections following mastectomy. NXT-41x combines biologics and extended antibiotic release to provide protection while supporting tissue regeneration.
- Revenue in USD (TTM)21.08m
- Net income in USD-22.99m
- Incorporated2015
- Employees51.00
- LocationElutia Inc12510 PROSPERITY DRIVE, SUITE 370SILVER SPRING 20904United StatesUSA
- Phone+1 (240) 247-1143
- Fax+1 (510) 307-9896
- Websitehttps://elutia.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthy Extracts Inc | 3.59m | -1.17m | 33.74m | 2.00 | -- | 1.40 | -- | 9.40 | -0.3195 | -0.3195 | 0.9095 | 1.43 | 0.2505 | 1.42 | 140.67 | 1,794,555.00 | -8.19 | -61.21 | -9.09 | -111.60 | 52.37 | 51.30 | -32.71 | -82.01 | 0.6491 | -2.84 | 0.0421 | -- | 25.24 | 32.99 | 66.01 | -- | -- | -- |
| BioXcel Therapeutics Inc | 752.00k | -68.21m | 34.55m | 37.00 | -- | -- | -- | 45.95 | -10.41 | -10.41 | 0.1023 | -4.45 | 0.016 | 0.9718 | 501.33 | 20,324.32 | -145.62 | -76.45 | -449.90 | -88.28 | -28.19 | -- | -9,070.61 | -14,760.23 | 1.16 | -3.25 | 5.40 | -- | 64.20 | -- | 66.71 | -- | -- | -- |
| Hyperion DeFi Inc | 345.32k | -26.40m | 35.08m | 13.00 | -- | 0.4191 | -- | 101.58 | -20.32 | -20.32 | 0.0385 | 9.88 | 0.0065 | -- | 1.06 | 26,563.08 | -48.31 | -102.28 | -59.47 | -168.53 | -798.11 | 60.58 | -7,385.51 | -856.97 | -- | -- | 0.0976 | -- | 1,412.93 | -- | -82.75 | -- | -0.6271 | -- |
| Celularity Inc | 40.58m | -80.71m | 36.48m | 123.00 | -- | -- | -- | 0.899 | -3.34 | -3.34 | 1.69 | -0.7121 | 0.3339 | 6.14 | 5.24 | 329,902.40 | -66.35 | -23.42 | -158.76 | -26.83 | 50.61 | -- | -198.75 | -294.70 | 0.123 | -6.57 | 2.01 | -- | 138.11 | -- | 70.51 | -- | -- | -- |
| Telomir Pharmaceuticals Inc | 0.00 | -11.25m | 37.48m | -- | -- | 5.28 | -- | -- | -0.3739 | -0.3739 | 0.00 | 0.2063 | 0.00 | -- | -- | -- | -266.47 | -- | -303.19 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -26.48 | -- | -- | -- |
| Talphera Inc | 28.00k | -12.46m | 37.79m | 13.00 | -- | 1.93 | -- | 1,349.68 | -0.3808 | -0.378 | 0.0009 | 0.4207 | 0.0011 | -- | -- | 2,153.85 | -48.15 | -14.86 | -54.44 | -19.40 | -- | -- | -44,503.57 | -446.19 | -- | -- | 0.00 | -- | -100.00 | -- | -26.41 | -- | -- | -- |
| Earth Science Tech Inc | 33.84m | 2.81m | 38.01m | 76.00 | 14.08 | 7.61 | 12.30 | 1.12 | 0.0092 | 0.0092 | 0.1114 | 0.0171 | 4.93 | 12.73 | 156.99 | 445,269.50 | 40.56 | 24.04 | 66.31 | -- | 72.21 | 71.08 | 8.22 | 5.50 | 0.7202 | 7.06 | 0.009 | -- | 177.05 | 128.98 | 300.63 | -- | -- | -- |
| Rockwell Medical Inc | 75.58m | -5.48m | 39.80m | 244.00 | -- | 1.08 | -- | 0.5266 | -0.1583 | -0.1583 | 2.20 | 0.9395 | 1.32 | 12.92 | 8.78 | 309,741.80 | -9.63 | -32.92 | -12.15 | -46.61 | 15.81 | 8.00 | -7.30 | -23.86 | 3.50 | -6.13 | 0.2141 | -- | 21.38 | 10.61 | 94.31 | -- | 11.47 | -- |
| BioScience Health Innovations Inc | 4.73m | 885.68k | 43.92m | -- | 206.50 | 25.67 | -- | 9.29 | 0.0194 | 0.0194 | 0.1313 | 0.1558 | 3.81 | 4.30 | 99.37 | -- | 71.34 | -- | 85.11 | -- | 63.64 | -- | 18.74 | -- | 3.47 | -- | 0.00 | -- | 208.73 | -- | 134.59 | -- | -- | -- |
| Elutia Inc | 21.08m | -22.99m | 44.84m | 51.00 | -- | -- | -- | 2.13 | -0.6006 | -0.6827 | 0.5347 | -1.03 | 0.5419 | 4.04 | 6.50 | 413,411.80 | -59.08 | -57.79 | -- | -128.41 | 45.97 | 42.77 | -109.03 | -92.86 | 0.396 | -- | -- | -- | -1.50 | -10.69 | -31.23 | -- | 2.54 | -- |
| Zhengye Biotechnology Holding Ltd | 22.25m | -2.80m | 45.54m | 277.00 | -- | 1.05 | 134.80 | 2.05 | -0.059 | -0.059 | 0.4787 | 0.9131 | 0.3099 | 1.62 | 2.04 | 80,341.63 | -4.60 | -- | -7.79 | -- | 37.37 | -- | -14.83 | -- | 1.10 | -7.00 | 0.1902 | -- | -11.95 | -- | -64.04 | -- | -- | -- |
| RADNOSTIX, INC. | 14.07m | -231.26k | 48.72m | 41.00 | -- | 11.89 | 289.47 | 3.46 | -0.0004 | -0.0004 | 0.0268 | 0.0078 | 0.8147 | 5.96 | 8.18 | 343,260.30 | -1.34 | 1.32 | -1.68 | 1.95 | 59.89 | 59.45 | -1.64 | 1.95 | 1.06 | -0.2928 | 0.5954 | 0.00 | 13.31 | 9.19 | 100.99 | -- | 28.22 | -- |
| Odonate Inc | 0.00 | -102.07m | 52.65m | 137.00 | -- | 2,022.38 | -- | -- | -108.70 | -108.70 | 0.00 | 74.17 | 0.00 | -- | -- | 0.00 | -66.98 | -58.36 | -83.00 | -65.14 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -12.99 | -- | -- | -- |
| Nasus Pharma Ltd | 0.00 | -1.19m | 53.18m | -- | -- | -- | -- | -- | -0.1319 | -0.1383 | 0.00 | -0.4762 | 0.00 | -- | -- | -- | -373.32 | -- | -- | -- | -- | -- | -- | -- | -- | -2.51 | -- | -- | -- | -- | -54.23 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to Elutia Inc's reporting currency: US Dollar USD
31.81%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nantahala Capital Management LLCas of 31 Dec 2025 | 3.18m | 7.89% |
| AIGH Capital Management LLCas of 31 Dec 2025 | 3.07m | 7.60% |
| SilverArc Capital Management LLCas of 31 Dec 2025 | 2.75m | 6.82% |
| Alyeska Investment Group LPas of 31 Dec 2025 | 1.28m | 3.18% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 1.02m | 2.54% |
| Perkins Capital Management, Inc.as of 31 Dec 2025 | 780.59k | 1.94% |
| Birchview Capital LPas of 31 Dec 2025 | 263.02k | 0.65% |
| Geode Capital Management LLCas of 31 Dec 2025 | 255.21k | 0.63% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 125.65k | 0.31% |
| Renaissance Technologies LLCas of 31 Dec 2025 | 102.12k | 0.25% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
